Md Ariful Haque

3.9k total citations · 2 hit papers
75 papers, 2.6k citations indexed

About

Md Ariful Haque is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Md Ariful Haque has authored 75 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 35 papers in Hematology and 19 papers in Rheumatology. Recurrent topics in Md Ariful Haque's work include Chronic Lymphocytic Leukemia Research (33 papers), Chronic Myeloid Leukemia Treatments (33 papers) and Eosinophilic Disorders and Syndromes (14 papers). Md Ariful Haque is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Chronic Myeloid Leukemia Treatments (33 papers) and Eosinophilic Disorders and Syndromes (14 papers). Md Ariful Haque collaborates with scholars based in China, United States and Germany. Md Ariful Haque's co-authors include Hagop M. Kantarjian, Andreas Hochhaus, Neil J. Gallagher, Timothy P. Hughes, Giuseppe Saglio, Dong‐Wook Kim, Richard A. Larson, Clarisse Lobo, Albert Hoenekopp and Richard E. Clark and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Md Ariful Haque

59 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2010 1.2k citations Giuseppe Saglio, Dong‐Wook Kim et al. profile →
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

2007 540 citations Hagop M. Kantarjian, Francis J. Giles et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Md Ariful Haque China	18	2.3k	2.0k	1.4k	313	253	75	2.6k
Fausto Castagnetti Italy	27	2.4k 1.0×	2.0k 1.0×	1.2k 0.9×	286 0.9×	313 1.2×	109	2.8k
Valentín García‐Gutiérrez Spain	20	1.7k 0.7×	1.4k 0.7×	768 0.6×	390 1.2×	162 0.6×	104	2.0k
Jamshid S. Khorashad United Kingdom	24	2.4k 1.1×	2.1k 1.0×	1.2k 0.9×	304 1.0×	296 1.2×	67	2.9k
Sebastian Kreil Germany	18	1.6k 0.7×	1.4k 0.7×	913 0.7×	227 0.7×	149 0.6×	58	2.0k
David T Yeung Australia	22	1.6k 0.7×	1.3k 0.6×	596 0.4×	358 1.1×	356 1.4×	131	2.3k
David Marín United Kingdom	29	3.3k 1.5×	2.7k 1.4×	1.6k 1.2×	473 1.5×	509 2.0×	114	4.0k
Marco Bua United Kingdom	18	2.3k 1.0×	2.0k 1.0×	1.3k 0.9×	246 0.8×	271 1.1×	32	2.6k
Malin Hultcrantz United States	22	1.5k 0.7×	1.1k 0.6×	463 0.3×	516 1.6×	121 0.5×	113	2.2k
Jeff H. Lipton Canada	17	820 0.4×	575 0.3×	289 0.2×	194 0.6×	106 0.4×	41	1.1k
Yousif Matloub United States	18	667 0.3×	444 0.2×	333 0.2×	179 0.6×	621 2.5×	48	1.3k

Countries citing papers authored by Md Ariful Haque

Since Specialization

Citations

This map shows the geographic impact of Md Ariful Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md Ariful Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md Ariful Haque more than expected).

Fields of papers citing papers by Md Ariful Haque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Md Ariful Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md Ariful Haque. The network helps show where Md Ariful Haque may publish in the future.

Co-authorship network of co-authors of Md Ariful Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Md Ariful Haque. A scholar is included among the top collaborators of Md Ariful Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Md Ariful Haque. Md Ariful Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haque, Md Ariful, Jianfeng Li, Manman Gao, & Zhiyu Zhou. (2025). Preparation of intervertebral disc organoid and regeneration mechanism based on gradient structure and mechanical function guidance: A Review. 2. 109–116.

Haque, Md Ariful, et al.. (2025). Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis. Frontiers in Neurology. 15. 1503342–1503342. 1 indexed citations

Haque, Md Ariful, et al.. (2025). Pulmonary Embolism: Highlighting Iron Deficiency Anemia as a Contributing Factor in the Development of Pulmonary Embolism—A Case Report. Clinical Case Reports. 13(2). e70158–e70158. 1 indexed citations

Haque, Md Ariful, et al.. (2025). A Literature Review on Childhood Pneumonia in Bangladesh: Reducing Mortality and Advancing SDG Goals. 13(1). 54–64.

Haque, Md Ariful, et al.. (2025). Cardiovascular outcomes and safety assessment of SGLT2i on heart failure patients: a systematic review and meta-analysis. Annals of Medicine and Surgery. 87(3). 1561–1568. 1 indexed citations

Song, Sang‐Hyun, et al.. (2025). Mapping the future of Kimchi: Omics insights, functional potential, and global standardization. Trends in Food Science & Technology. 166. 105358–105358.

Islam, Md. Ariful, et al.. (2024). Radiation recall dermatitis in HER 2 positive breast cancer patients triggered by trastuzumab: A rare case report and review of literature. International Journal of Surgery Case Reports. 120(C). 109864–109864. 3 indexed citations

Khan, Kiran Shafiq, et al.. (2024). Co‐occurrence of Guillain–Barre syndrome and rheumatoid arthritis in a young female: A case report from a low middle‐income country. SHILAP Revista de lepidopterología. 12(2). e8481–e8481. 1 indexed citations

Raja, Adarsh, et al.. (2024). Efficacy and safety of Donidalorsen in Hereditary Angioedema with C1 inhibitor deficiency: a systematic review and a meta analysis. Archives of Dermatological Research. 317(1). 110–110. 1 indexed citations

10.

Haque, Md Ariful, et al.. (2024). The fight against malaria: a new hope with the R21 vaccine. International Journal of Surgery Global Health. 7(2).

11.

Haque, Md Ariful, et al.. (2024). Effects of Android phone vs. iPhone use on BlackBerry thumb symptoms among university students in Bangladesh. SHILAP Revista de lepidopterología. 29(1).

12.

Islam, Md. Ariful, et al.. (2024). Trastuzumab‐induced toxic epidermal necrolysis in a Her‐2‐positive metastatic breast cancer patient—A rare case report. SHILAP Revista de lepidopterología. 12(7). e9103–e9103. 1 indexed citations

13.

Kumar, Vijay, et al.. (2024). Contagion comeback: unravelling the measles outbreak across the USA. Frontiers in Public Health. 12. 1491927–1491927. 1 indexed citations

14.

Haque, Md Ariful, Marcos Roberto Tovani‐Palone, Thomas Franchi, et al.. (2022). Optimal configuration of a three-rod ortho-bridge system in the treatment of Vancouver type B1 periprosthetic femoral fractures: A finite element analysis. Journal of Orthopaedics. 30. 120–126. 1 indexed citations

15.

Islam, Zarmina, et al.. (2022). Typhoid in Bangladesh: Challenges, efforts, and recommendations. Annals of Medicine and Surgery. 80. 104261–104261. 8 indexed citations

16.

Khan, Abid Hasan, et al.. (2022). Factors associated with suicidal behavior among university students in Bangladesh after one year of COVID-19 pandemic. Heliyon. 8(1). e08782–e08782. 9 indexed citations

17.

Mamun, Mohammed A., Imran Hossain, Md Atikur Rahman, et al.. (2020). Financial threat, hardship and distress predict depression, anxiety and stress among the unemployed youths: A Bangladeshi multi-city study. Journal of Affective Disorders. 276. 1149–1158. 58 indexed citations

18.

Hughes, Timothy P., Giuseppe Saglio, Susan Branford, et al.. (2009). Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase. Journal of Clinical Oncology. 27(25). 4204–4210. 236 indexed citations

19.

Coutre, Philipp le, Francis J. Giles, Jane F. Apperley, et al.. (2008). Nilotinib in accelerated phase chronic myelogenous leukemia (CML-AP) patients with imatinib-resistance or -intolerance: Update of a phase II study. Journal of Clinical Oncology. 26(15_suppl). 7050–7050. 15 indexed citations

20.

Hughes, Timothy P., Giuseppe Saglio, Giovanni Martinelli, et al.. (2007). Responses and Disease Progression in CML-CP Patients Treated with Nilotinib after Imatinib Failure Appear To Be Affected by the BCR-ABL Mutation Status and Types.. Blood. 110(11). 320–320. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact